ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma

Sun, Zhongqi; Shi, Zhongxing; Xin, Yanjie; Zhao, Sheng; Jiang, Hao; Li, Jinping; Li, Jiaping; Jiang, Huijie哈尔滨医科大学; 中山大学; 1
ACADEMIC RADIOLOGY2023-9DOI: 10.1016/j.acra.2022.12.031
4被引9阅读
引用收藏
分享

摘要

Rationale and Objectives: Accurate prediction of treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) is critical for precision treatment. This study aimed to develop a comprehensive model (DLRC) that incorporates contrast-enhanced computed tomography (CECT) images and clinical factors to predict the response to TACE in patients with HCC. @@@ Materials and Methods: A total of 399 patients with intermediate-stage HCC were included in this retrospective study. Deep learning and radiomic signatures were established based on arterial phase CECT images, Correlation analysis and the least absolute shrinkage and selection (LASSO) regression analysis were applied for features selection. The DLRC model incorporating deep learning radiomic signatures and clinical factors was developed using multivariate logistic regression. The area under the receiver operating characteristic curve (AUC), calibration curve and decision curve analysis (DCA) were used to evaluate the performance of the models. Kaplan-Meier survival curves based on the DLRC were plotted to assess overall survival in the follow-up cohort (n = 261). @@@ Results: The DLRC model was developed using 19 quantitative radiomic features, 10 deep learning features, and 3 clinical factors. The AUC of the DLRC model was 0.937 (95% confidence interval [CI], 0.912-0.962) and 0.909 (95% CI, 0.850-0.968) in the training and validation cohorts, respectively, outperforming models established with two signatures or a single signature (p < 0.05). Stratified analysis showed that the DLRC was not statistically different between subgroups (p > 0.05), and the DCA confirmed the greater net clinical benefit. In addition, multivariable cox regression revealed that DLRC model outputs were independent risk factors for the overall survival (hazard ratios: 1.20, 95% CI: 1.03-1.40; p = 0.019). @@@ Conclusion: The DLRC model exhibited a remarkable accuracy in predicting response to TACE, and it can be utilized as a potent tool for precision treatment.

学科与关键词

关键词
Hepatocellular carcinomaTransarterial chemoembolizationCTRadiomicsDeep learning
相关
加载中…
  • Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning
    Peng, Jie*; Huang, Jinhua*; Huang, Guijia; Zhang, JingFrontiers in Oncology, 2021, 11: 730282.被引 16
  • An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhang, Lu; Jin, Zhe; Li, Chen; He, Zicong; Zhang, Bin; Chen, Qiuying; You, Jingjing; Ma, Xiao; Shen, Hui; Wang, Fei; Wu, Lingeng*; Ma, Cunwen*; Zhang, Shuixing*Radiologia Medica, 2024.
  • Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos
    Zhang, Lu; Jiang, Yicheng; Jin, Zhe; Jiang, Wenting; Zhang, Bin; Wang, Changmiao; Wu, Lingeng; Chen, Luyan; Chen, Qiuying; Liu, Shuyi; You, Jingjing; Mo, Xiaokai; Liu, Jing; Xiong, Zhiyuan; Huang, Tao; Yang, Liyang; Wan, Xiang; Wen, Ge*; Han, Xiao Guang*; Fan, Weijun*; Zhang, Shuixing*CANCER IMAGING, 2022, 22(1): 23.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
ACADEMIC RADIOLOGY
发表日期
2023-09
卷期
第 30 卷
页码
S81-S91
DOI
10.1016/j.acra.2022.12.031
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2019YFC0118100]; National Natural Science Foundation of China [81873910, 62171167]; China Postdoctoral Science Foundation [2021MD703827]

作者

  • S

    Sun, Zhongqi (第一作者)

    2 · harbin med univ

  • S

    Shi, Zhongxing

    2 · harbin med univ

查看全部 8 位作者收起作者
  • X

    Xin, Yanjie

    2 · harbin med univ

  • Z

    Zhao, Sheng

    2 · harbin med univ

  • J

    Jiang, Hao

    2 · harbin med univ

  • L

    Li, Jinping

  • L

    Li, Jiaping

  • J

    Jiang, Huijie

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417